azathioprine has been researched along with Myelomonocytic Leukemia, Chronic in 4 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with prednisolone and azathioprine was initiated." | 1.30 | [Pyoderma gangrenosum and portal vein thrombosis in a 33-year-old female patient]. ( Berr, F; Halm, U; Mössner, J; Paasch, U; Pönisch, W; Schiefke, I, 1999) |
| "Endoscopic examination revealed esophageal cancer." | 1.29 | [Chronic myelomonocytic leukemia and esophageal cancer developed in a renal allograft recipient]. ( Fujita, N; Goto, H; Inaba, T; Itoh, K; Misawa, S; Murakami, S; Nakagawa, M; Oku, N; Shima, T; Shimazaki, C, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rogalski, C | 1 |
| Paasch, U | 2 |
| Glander, HJ | 1 |
| Haustein, UF | 1 |
| Fukuda, M | 1 |
| Horibe, K | 1 |
| Miyajima, Y | 1 |
| Matsumoto, K | 1 |
| Kozaki, T | 1 |
| Komiyama, A | 1 |
| Shima, T | 1 |
| Oku, N | 1 |
| Goto, H | 1 |
| Inaba, T | 1 |
| Murakami, S | 1 |
| Itoh, K | 1 |
| Fujita, N | 1 |
| Shimazaki, C | 1 |
| Misawa, S | 1 |
| Nakagawa, M | 1 |
| Schiefke, I | 1 |
| Halm, U | 1 |
| Pönisch, W | 1 |
| Berr, F | 1 |
| Mössner, J | 1 |
4 other studies available for azathioprine and Myelomonocytic Leukemia, Chronic
| Article | Year |
|---|---|
Bullous pyoderma gangrenosum complicated by disseminated intravascular coagulation with subsequent myelodysplastic syndrome (chronic myelomonocytic leukemia).
Topics: Administration, Oral; Adult; Azathioprine; Bandages, Hydrocolloid; Colloids; Diagnosis, Differential | 2003 |
[Chronic myelomonocytic leukemia developed 9 years after the diagnosis of idiopathic thrombocytopenic purpura in a child].
Topics: Adolescent; Azathioprine; Combined Modality Therapy; Female; Humans; Leukemia, Myelomonocytic, Chron | 1994 |
[Chronic myelomonocytic leukemia and esophageal cancer developed in a renal allograft recipient].
Topics: Azathioprine; Carcinoma, Squamous Cell; Esophageal Neoplasms; Humans; Immunosuppression Therapy; Kid | 1993 |
[Pyoderma gangrenosum and portal vein thrombosis in a 33-year-old female patient].
Topics: Adult; Anti-Inflammatory Agents; Anticoagulants; Antineoplastic Agents; Ascites; Azathioprine; Bone | 1999 |